Apex Medical Corp. (4106.TW)
TWD 24.5
(1.24%)
TWD 24.5
(1.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.64 Billion | 2.66 Billion | 2.37 Billion | 2 Billion | 2.03 Billion | 2.1 Billion |
| Cost of Revenue | 1.5 Billion | 1.59 Billion | 1.38 Billion | 1.15 Billion | 1.18 Billion | 1.22 Billion |
| Gross Profit | 1.13 Billion | 1.06 Billion | 986.95 Million | 847.63 Million | 853.81 Million | 876.87 Million |
| Operating Expenses | 944.09 Million | 880.66 Million | 882.94 Million | 750.81 Million | 719.35 Million | 740.02 Million |
| Selling, General and Administrative Expenses | 778.33 Million | 726.38 Million | 732.19 Million | 582.98 Million | 581.16 Million | 607.86 Million |
| Research and Development Expenses | 165.76 Million | 154.28 Million | 150.74 Million | 167.82 Million | 138.19 Million | 132.16 Million |
| Other Expenses | - | 22.52 Million | 38.56 Million | 19.03 Million | 9.42 Million | 27.34 Million |
| Cost and Expenses | 2.45 Billion | 2.47 Billion | 2.27 Billion | 1.9 Billion | 1.9 Billion | 1.96 Billion |
| Operating Income | 194.21 Million | 211.9 Million | 145.43 Million | 132 Million | 152.12 Million | 136.84 Million |
| Interest Expense | 14.18 Million | 10.18 Million | 7.67 Million | 9.28 Million | 17.99 Million | 9.68 Million |
| Income Tax Expense | 56.84 Million | 38.42 Million | 34.57 Million | 19.46 Million | 39.62 Million | 40.95 Million |
| Earnings before Tax | 209.85 Million | 200.53 Million | 138.08 Million | 124.84 Million | 128.42 Million | 150.27 Million |
| Net Income | 152.17 Million | 161.4 Million | 102.24 Million | 104.58 Million | 87.92 Million | 108.41 Million |
| Earnings Per Share Basic | 1.51 | 1.60 | 1.01 | 1.04 | 0.87 | 1.17 |
| Earnings Per Share Diluted | 1.50 | 1.59 | 1.01 | 1.03 | 0.87 | 1.13 |
| Weighted Average Shares Outstanding | 100.91 Million | 100.91 Million | 100.91 Million | 100.91 Million | 100.91 Million | 92.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 101.57 Million | 101.53 Million | 101.32 Million | 101.33 Million | 101.3 Million | 95.91 Million |
| Gross Margin | 0.43 | 0.40 | 0.42 | 0.42 | 0.42 | 0.42 |
| EBIT Margin | 0.12 | 0.11 | 0.10 | 0.11 | 0.11 | 0.11 |
| Profit Margin | 0.06 | 0.06 | 0.04 | 0.05 | 0.04 | 0.05 |
| EBITDA | 318.12 Million | 305.21 Million | 238.98 Million | 211.28 Million | 232.96 Million | 226.13 Million |
| Earnings Before Tax Margin | 0.07 | 0.08 | 0.06 | 0.07 | 0.07 | 0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 584.36 Million | 646.68 Million | 678.87 Million | 2.64 Billion | 564.86 Million | 703.61 Million |
| Cost of Revenue | 320.72 Million | 366.21 Million | 371.72 Million | 1.5 Billion | 319.74 Million | 414.94 Million |
| Gross Profit | 263.63 Million | 280.46 Million | 307.15 Million | 1.13 Billion | 245.12 Million | 288.66 Million |
| Operating Expenses | 234.86 Million | 231.74 Million | 258.41 Million | 944.09 Million | 222.21 Million | 221.75 Million |
| Selling, General and Administrative Expenses | 190.39 Million | 192.67 Million | 210.33 Million | - | 183.86 Million | 182.77 Million |
| Research and Development Expenses | 44.47 Million | 39.15 Million | 47.42 Million | - | 38.35 Million | 38.97 Million |
| Other Expenses | 820 Thousand | -231.74 Million | -258.41 Million | -944.09 Million | 16.7 Million | 10.75 Million |
| Cost and Expenses | 555.59 Million | 597.96 Million | 630.13 Million | 2.45 Billion | 541.95 Million | 636.69 Million |
| Operating Income | 28.76 Million | 48.71 Million | 48.74 Million | 194.21 Million | 40.56 Million | 78.66 Million |
| Interest Expense | 3.67 Million | 3.64 Million | 3.8 Million | 14.18 Million | 3.37 Million | 3.25 Million |
| Income Tax Expense | 5.98 Million | 12.36 Million | 6.01 Million | 56.84 Million | 12.94 Million | 24.03 Million |
| Earnings before Tax | 27.6 Million | 52.05 Million | 32.99 Million | 209.85 Million | 37.08 Million | 75.03 Million |
| Net Income | 21.24 Million | 40.01 Million | 26.62 Million | 152.17 Million | 23.95 Million | 50.85 Million |
| Earnings Per Share Basic | 0.21 | 0.40 | 0.26 | - | 0.24 | 0.50 |
| Earnings Per Share Diluted | 0.21 | 0.39 | 0.26 | - | 0.24 | 0.50 |
| Weighted Average Shares Outstanding | 100.91 Million | 100.03 Million | 100.91 Million | 100.91 Million | 100.91 Million | 100.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 101.1 Million | 102.59 Million | 101.82 Million | 101.57 Million | 101.01 Million | 101.02 Million |
| Gross Margin | 0.45 | 0.43 | 0.45 | 0.43 | 0.43 | 0.41 |
| EBIT Margin | 0.09 | 0.12 | 0.09 | - | 0.11 | 0.14 |
| Profit Margin | 0.04 | 0.06 | 0.04 | 0.06 | 0.04 | 0.07 |
| EBITDA | 52.64 Million | 78.39 Million | 61.43 Million | - | 64.69 Million | 101.32 Million |
| Earnings Before Tax Margin | 0.05 | 0.08 | 0.07 | 0.07 | 0.07 | 0.11 |
4760
ACGBF
000825
6875
3131
2062